Download FREE Report Sample
Download Free sampleMesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
Mesalazine Market contains market size and forecasts of Mesalazine in global, including the following market information:
Global Mesalazine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mesalazine Market Sales, 2017-2022, 2023-2028, (Ton)
Global top five Mesalazine companies in 2021 (%)
The global Mesalazine market was valued at 152.8 million in 2021 and is projected to reach US$ 200 million by 2028, at a CAGR of 3.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ? 97 % Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm and Lasa Loboratory, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mesalazine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesalazine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Mesalazine Market Segment Percentages, by Type, 2021 (%)
Purity ? 97 %
Purity ? 98 %
Purity ? 99 %
Global Mesalazine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Mesalazine Market Segment Percentages, by Application, 2021 (%)
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
Global Mesalazine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Mesalazine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesalazine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mesalazine revenues share in global market, 2021 (%)
Key companies Mesalazine sales in global market, 2017-2022 (Estimated), (Ton)
Key companies Mesalazine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
